Selling And Administration Expenses 更改
Bausch Health Companies USD 850M 18M 2024-09
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Merck USD 2.85B 148M 2024-12
Novartis USD 3.5B 368M 2024-12
Novo Nordisk 16.59B 501M 2024-09
Novo Nordisk DKK 16.59B 501M 2024-09
Pacira USD 79.61M 5.28M 2024-12
Sanofi EUR 2.68B 26M 2024-09
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Novo Nordisk A/S 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Apr 2025.